Series B - SAB Biotherapeutics - Jul 17, 2020 Funding Round Profile - Cointime

Bitcoin $79,806.15 +4.84%
Ethereum $3,216.44 +6.17%
BNB $641.37 +3.47%
Optimism $1.72 +7.19%
Arbitrum $0.64 +8.27%
Solana $211.23 +7.25%
Polygon $0.41 +9.38%
Cosmos $5.40 +15.30%
Avalanche $32.53 +12.53%

Bitcoin $79,806.15 +4.84%
Ethereum $3,216.44 +6.17%
BNB $641.37 +3.47%
Optimism $1.72 +7.19%
Arbitrum $0.64 +8.27%
Solana $211.23 +7.25%
Polygon $0.41 +9.38%
Cosmos $5.40 +15.30%
Avalanche $32.53 +12.53%

SAB Biotherapeutics

company

Funding Round

Series B

Money Raised

$ 14M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Merck	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 7, 2016	Grant	$ 1.42M	National Institutes of Health	Detail